CNS pipeline · person
Tim Rudolphi, MBA
Chief Commercial Officer at Emalex Biosciences, leading commercial preparations and business development. He has more than 30 years of experience in the biopharmaceutical and MedTech industries, having led or participated in the launch of 16 products. Previously he served as CEO of metaMe Health and chief business officer at Aprecia Pharmaceuticals, and was one of the first 30 employees at Takeda Pharmaceuticals U.S. He earned his MBA from Marquette University and a B.S. from the University of Illinois.
- 1 company
Courtesy Emalex Biosciences
Current roles
- Emalex Biosciences Inc.Chief Commercial Officer · Executive
Appears with
People sharing a company with Tim.
- Brent Paul · Emalex Biosciences Inc.
- Christine H. Soulje · Emalex Biosciences Inc.
- Christopher Wilson · Emalex Biosciences Inc.
- David Kim · Emalex Biosciences Inc.
- David Knouft · Emalex Biosciences Inc.
- Doug Frandsen · Emalex Biosciences Inc.
- Eric Messner · Emalex Biosciences Inc.
- Frederick Munschauer · Emalex Biosciences Inc.
- Gail Hartigan · Emalex Biosciences Inc.
- George Karkanias · Emalex Biosciences Inc.
- Harry Jordan · Emalex Biosciences Inc.
- Jay White · Emalex Biosciences Inc.
- Jeffrey S. Aronin · Emalex Biosciences Inc.
- John Flatt · Emalex Biosciences Inc.
- Jose (Jesse) Zapata · Emalex Biosciences Inc.
- Joy Schleyer · Emalex Biosciences Inc.
- Ken Borgerding · Emalex Biosciences Inc.
- Lydia Shenouda · Emalex Biosciences Inc.
- Meredith M. Miller · Emalex Biosciences Inc.
- Paul Reinfelds · Emalex Biosciences Inc.
- Sarah Atkinson · Emalex Biosciences Inc.
- Tom Stothoff · Emalex Biosciences Inc.
- Tracy Durgin · Emalex Biosciences Inc.
- Trish Rice · Emalex Biosciences Inc.
People and affiliation data assembled from public company disclosures, SEC filings, and conference materials — every record source-cited under psychiatrist-authored guardrails.